Randomized Comparison of Sirolimus-Eluting and Everolimus-Eluting Coronary Stents in the Treatment of Total Coronary Occlusions | Zendy

Raúl Moreno | Zendy; Eulogio Garcı́a | Zendy; Rui Campante Teles | Zendy; José Ramón Rumoroso | Zendy; Henrique Carvalho | Zendy; Francisco Javier Goicolea | Zendy; José Moreu | Zendy; Josefa Mauri | Zendy; Manel Sabaté | Zendy; Vicente Mainar | Zendy; Lino Patrício | Zendy; Mariano Valdés | Zendy; Felipez Fernández Vázquez | Zendy; Ángel SánchezRecalde | Zendy; Guillermo Galeote | Zendy; Santiago JiménezValero | Zendy; Manuel Almeida | Zendy; Esteban López de Sá | Zendy; Luís Calvo | Zendy; Ignacio Plaza | Zendy; J L López-Sendón | Zendy; Jose-Luis R. Martín | Zendy

Open Access

Randomized Comparison of Sirolimus-Eluting and Everolimus-Eluting Coronary Stents in the Treatment of Total Coronary Occlusions

Author(s) -

Raúl Moreno,

Eulogio Garcı́a,

Rui Campante Teles,

José Ramón Rumoroso,

Henrique Carvalho,

Francisco Javier Goicolea,

José Moreu,

Josefa Mauri,

Manel Sabaté,

Vicente Mainar,

Lino Patrício,

Mariano Valdés,

Felipez Fernández Vázquez,

Ángel SánchezRecalde,

Guillermo Galeote,

Santiago JiménezValero,

Manuel Almeida,

Esteban López de Sá,

Luís Calvo,

Ignacio Plaza,

J L López-Sendón,

Jose-Luis R. Martín

Publication year - 2013

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.000076

Subject(s) - medicine , sirolimus , stent , everolimus , restenosis , cardiology , clinical endpoint , randomized controlled trial , surgery

Patients with coronary total occlusions are at especially high risk for restenosis and new revascularizations. Sirolimus-eluting stents dramatically improved the clinical outcome of this subset of patients in randomized trials, but other drug-eluting stents, mainly the everolimus-eluting stent (currently the most frequently used stent), have not yet been evaluated in patients with coronary total occlusions. The objective was to compare the second-generation everolimus-eluting stent with the first-generation sirolimus-eluting stent in patients with coronary total occlusions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research